Satyarth Pandey (He/Him)

PhD Student @TechnionLive. T cells, Aging, mitochondria, iron and metabolism.
Project Coordinator @sci_community_

[Chandana Basu @cbm2577]

so glad to have contributed to this. :) Thanks @Dhairya_Rajguru and @ImmuneSat for inviting. A great platform and kudis to both of u for the brilliant work.

[Satyarth Pandey (He/Him) @ImmuneSat]

@cbm2577 @Dhairya_Rajguru Thank you @cbm2577 means alot

[IndiaBioscience.org @IndiaBioscience]

The Scicomm Synapse is building a vibrant, student-led space where scientists share their journeys beyond the lab.

A story by Satyarth Pandey (@ImmuneSat), Deven Matkari & Dhairya Rajguru (@Dhairya_Rajguru) - https://t.co/zjh0WB9v2C

[Satyarth Pandey (He/Him) @ImmuneSat]

Happening this Sunday at 10:30 AM IST.
Join us for an exciting conversation with @vinita_gowda

[the.scicomm.synapse @Sci_community_]

🔬🌱 Live Interactive Science Podcast – The Next Experiment

🎙️ Topic: Tracing Plant History Through Evolution
👩‍🔬 Speaker: Dr. Vinita Gowda, Professor, IISER Bhopal
📅 Date: 7 June 2026
🕥 Time: 10:30 AM (IST)

🔗 Register here: https://t.co/avEFNuMg6n

[the.scicomm.synapse @Sci_community_]

Science thrives on diverse perspectives.

🏳️‍🌈 Happy Pride Month from our science community.

#PrideMonth #ScienceForEveryone #LGBTQInSTEM #STEM #ScienceCommunication #Research #DiversityInScience #InclusiveScience

[Madam Mitochondria @Madam_Mito]

Instead of asking “What damage causes aging?”

Researchers must ask, “Why do young organisms recover from stress while old organisms cannot?”

[Samatha Mathew (She/her) @Samatha_Mathew]

Glad to have been the project lead on putting together this report, which gave me the feel of how to look at country wide data and tell a compelling story with a cascading impact.

Thanks to the @Sci_Rio team, especially @ChampakSuchitha and @smarter_INDIANS for closing this 🎉

[the.scicomm.synapse @Sci_community_]

Still staring at a blank document, unsure where to start your thesis or paper?

Learn to use AI 💡to simplify scientific writing, brainstorm better while staying original and ethical ✨🚀

📅 24 May | 10:00 AM ist
Registration Link 🔗
https://t.co/HcCqv72UD0

[Khoa Vu @KhoaVuUmn]

Must have been a rough tenure track.

[Ragothaman Yennamalli @StructBioinfo]

@cbm2577 For Indian context, I would say that students should stop treating manuscript writing, thesis writing and any scientific writing as homework. It never ends. It need not be perfect.

[Gautam Menon @MenonBioPhysics]

Sensible, measured and direct communication from the WHO head.

[Emma Hilton @FondOfBeetles]

On Hantavirus: a (non-technical) thread.

Disclaimer: I am a biology PhD, but not virology/epidemiology. Husbandman is a virology PhD. But I’m told I’m good at communicating science, so here’s my take.

#Hantavirus

[Satyarth Pandey (He/Him) @ImmuneSat]

Excited to share my latest blog is now live with @SpringerNature
Hope it helps many prospective students.
Why are publications not “everything” for graduate school interview calls? https://t.co/7xumiDC4yM #

[the.scicomm.synapse @Sci_community_]

New blog out now.

New blog out now.
In this conversation, Prof. L. S. Shashidhara reflects on leadership, research culture, interdisciplinary thinking and the future of Indian science.

Read the full blog here: https://t.co/ndJOyQn84q

#IndianScience #Research #Leadership

[Satyarth Pandey (He/Him) @ImmuneSat]

@Nefalibata_ @the_Node @rrbehringer @InSDB_79 @intlsocdiff @IISER_BERHAMPUR Congrats!!

[Satyarth Pandey (He/Him) @ImmuneSat]

Happy to welcome @payal_jos at @Sci_community_ this sunday at 10:30 AM. Do register!!

[the.scicomm.synapse @Sci_community_]

📢 Live interactive science podcast 🔬

Transitioning from Academia to industry 🎙️ in conversation with
Dr. Payal Joshi
Director and Head of Operations and Method
Development at Shefali Research Laboratories, Mumbai, India

📅 May 03 | 10:30 AM
🔗 https://t.co/ubnBOob8v8

[Satyarth Pandey (He/Him) @ImmuneSat]

Happening now not 11;30- and we are live now: https://t.co/mppephxA0L

[Satyarth Pandey (He/Him) @ImmuneSat]

Happening this Sunday at 11:30 AM IST. Do register!!

[the.scicomm.synapse @Sci_community_]

Science isn’t just data, it’s a story. 🧪📖 Join award winning journalist Sayantan Datta LIVE to learn the art of science storytelling! 🎙️
​🗓 April 19 | 11:30 AM IST
🔗 https://t.co/dlQqqwTug4

#scicomm

[The Nobel Prize @NobelPrize]

Did you know that we have millions of different antibodies, but each individual white blood cell produces only one kind of antibody? By fusing an antibody-producing cell with a tumour cell Georges Köhler and César Milstein were able to produce antibodies in large amounts.

[Michael @neolithicrumba2]

Let’s talk about the science behind late or missed doses.

A 🧵

First, let’s understand where the data comes from. When a new drug is developed, it is testing in a lab, putting the new molecule in a dish with HIV. If successful, it’s tested in animals, and then a small group of people (around a dozen in a phase I study) not to find out if it works, but to find out if the drug is safe and how long it stays in the bloodstream.

These volunteers are kept in a hospital-like setting and their blood is taken every few hours. This determines the drug’s half life, or how long half the dose remains in their body.

For a drug like dolutegravir (the D in TLD), the half life is around 14 hours. That tells the researchers that it can be dosed one time a day.

More specifically, they’re looking for IC90, which is the time 90% is still suppressed. With dolutegravir, that’s 30 hours, so a full effective dose is still in the bloodstream for more than one day.

Next up: phase II tesing

[Rishabh @MBHRishabh]

In this piece for @SciPublic's blog companion, I reflect on the fate of “scientific temper” in India as it sits amidst misinformation, mythic claims, and brittle forms of authority.

https://t.co/i5dPPoel2Y